Phase III trial: Ocrevus twice yearly w/10-minute subcutaneous injection on: July 13, 2023, 09:52:06 am #1 Maybe Ocrevus will be available as a twice-yearly 10-minute subcutaneous injection. It's not clear whether the injection can be self-administered but my guess is that the person with MS would need to go to a medical facility for the injection.From Business Wire (July 13, 2023)--"Positive Phase III results for Genetech's Ocrevus (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis": https://bit.ly/3DcjV7T Last Edit: July 13, 2023, 09:55:03 am by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
Positive results found for new Ocrevus subcutaneous formulation Reply #1 on: July 14, 2023, 09:45:49 pm #2 This article makes it clear that the 10-minute subcutaneous version of Ocrevus isn't meant to be self-administered. The patient would go to an MS center for the injections, presumably.From Multiple Sclerosis News Today (July 14, 2023)--"Positive results found for new Ocrevus under-the-skin formulation": Positive results found for under-the-skin Ocrevus formulation in... A new formulation of Ocrevus, given as a 10-minute under-the-skin injection, was found comparable to the approved version of the MS therapy. Multiple Sclerosis News Today · multiplesclerosisnewstoday.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
Subcutaneous Ocrevus similar to IV treatment for patients w/PPMS or RMS Reply #2 on: September 19, 2023, 09:22:30 pm #3 From Practical Neurology (July 23, 2023)--"Subcutaneous Ocrevus Similar to IV Treatment for Patients with PPMS or RMS": Subcutaneous Ocrevus Similar to IV Treatment for Patients with PPMS or RMS Subcutaneous injection of Ocrevus (ocrelizumab; Genentech, South San Francisco, CA) was comparable to the intravenous (IV) infusion formulation of Ocrevus… tinyurl.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
(ECTRIMS) New under-the-skin Ocrevus found effective in MS Reply #3 on: October 12, 2023, 04:35:59 pm #4 From Multiple Sclerosis News Today (October 12, 2023)--"ECTRIMS 2023: New under-the-skin Ocrevus found effective in MS": ECTRIMS 2023: New under-the-skin Ocrevus found effective in MS |... Most MS patients treated with a new under-the-skin formulation of Ocrevus had no relapses or new MRI activity over six months, data show. Multiple Sclerosis News Today · bit.ly Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
